Reference Source

SHEN ZHEN EVERGREEN BIO-HEALTH TECHNOLOGY · 99-39 · CHINA

For SHEN ZHEN EVERGREEN BIO-HEALTH TECHNOLOGY · 99-39 · CHINA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is CHINA; product is Chlorella 1000 Tablets (250g) dietary supplement | Chlorella Powder 8 oz dietary supplement | Chlorella 1000 Tablets (250g) dietary supplement | Chlorella Powder 8 oz dietary supplement | Chlorella 1000 Tablets (250g) dietary supplement; product code is 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 54 Y - - 03 Chlorella (tablet), Vit/Min/Protein/Unconventional Dietary Spec for Human/Animal, n.e.c.) | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 09/12/2024; address is Block D Room 1105 , Longcheng Street , Shenzhen, CHINA, verified against its source on 2026-09-16.

Firm
SHEN ZHEN EVERGREEN BIO-HEALTH TECHNOLOGY verified
Import alert
99-39
Import alert name
Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
Country
CHINA verified
Address
Block D Room 1105 , Longcheng Street , Shenzhen, CHINA verified
Date published
09/12/2024 verified
Product code
41 Y - - 99 Dietary Conventional Foods, N.E.C. | 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 54 Y - - 03 Chlorella (tablet), Vit/Min/Protein/Unconventional Dietary Spec for Human/Animal, n.e.c.) | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. each item verified
Product
Chlorella 1000 Tablets (250g) dietary supplement | Chlorella Powder 8 oz dietary supplement | Chlorella 1000 Tablets (250g) dietary supplement | Chlorella Powder 8 oz dietary supplement | Chlorella 1000 Tablets (250g) dietary supplement each item verified
FDA notes
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. | The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(a)(1) of the Act [21 U.S.C. 343(a)(1)] in that the label is false or misleading. Section 403(q)(1)(A) of the Act [21 U.S.C. 343(q)(1)(A)] because the serving size declared on the label is incorrect. Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. | The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. | The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(a)(1) of the Act [21 U.S.C. 343(a)(1)] in that the label is false or misleading. Section 403(q)(1)(A) of the Act [21 U.S.C. 343(q)(1)(A)] because the serving size declared on the label is incorrect. Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. | The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

SHEN ZHEN EVERGREEN BIO-HEALTH TECHNOLOGY Date Published : 09/12/2024 Block D Room 1105 , Longcheng Street , Shenzhen, CHINA 41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 09/12/2024 Desc: Chlorella 1000 Tablets (250g) dietary supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. 41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 09/12/2024 Desc: Chlorella Powder 8 oz dietary supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(a)(1) of the Act [21 U.S.C. 343(a)(1)] in that the label is false or misleading. Section 403(q)(1)(A) of the Act [21 U.S.C. 343(q)(1)(A)] because the serving size declared on the label is incorrect. Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. 54 Y - - 03 Chlorella (tablet), Vit/Min/Protein/Unconventional Dietary Spec for Human/Animal, n.e.c.) Date Published: 09/12/2024 Desc: Chlorella 1000 Tablets (250g) dietary supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 09/12/2024 Desc: Chlorella Powder 8 oz dietary supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(a)(1) of the Act [21 U.S.C. 343(a)(1)] in that the label is false or misleading. Section 403(q)(1)(A) of the Act [21 U.S.C. 343(q)(1)(A)] because the serving size declared on the label is incorrect. Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 09/12/2024 Desc: Chlorella 1000 Tablets (250g) dietary supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1].

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.